Rutong T. Yu
99 West Huai Hai Road
Xuzhou, 221002, China
Xuzhou, 221002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Retraction Note: Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway.
Journal: Journal of neuro-oncology
Published: April 20, 2026
The WW domain presents a promising target for the development of PCIF1 agonists in the treatment of glioma.
Journal: NPJ precision oncology
Published: November 27, 2024
Retraction Note: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway.
Journal: Cancer cell international
Published: September 13, 2024
Dual blockade of EGFR and PI3K signaling pathways offers a therapeutic strategy for glioblastoma.
Journal: Cell communication and signaling : CCS
Published: August 03, 2023
Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment.
Journal: Journal of translational medicine
Published: March 24, 2023
Chronic stress accelerates glioblastoma progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 10, 2023
Drug repositioning: Using psychotropic drugs for the treatment of glioma.
Journal: Cancer letters
Published: October 04, 2021
GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma.
Journal: Cell death discovery
Published: August 08, 2021
Multi-responsive nanofibers composite gel for local drug delivery to inhibit recurrence of glioma after operation.
Journal: Journal of nanobiotechnology
Published: March 05, 2021
GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death.
Journal: Cell death & disease
Published: February 27, 2021
Last Updated: 09/26/2026